Screener
CONMED CNMD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 55.8%-0.3pp | 55.2%-1.0pp | 54.6%-1.5pp | 54.2%-1.4pp | 56.1%+0.7pp | |
| Operating margin | 8%-5.0pp | 8.2%-5.6pp | 7.5%-7.9pp | 8.8%-6.6pp | 13%+0.2pp | |
| Net margin | 4.1%-4.2pp | 4%-5.0pp | 3.4%-6.7pp | 4.8%-5.5pp | 8.3%+0.6pp | |
| Returns | ||||||
| Return on equity | 5.5%-6.2pp | 5.5%-7.5pp | 4.7%-10.0pp | 6.6%-8.6pp | 11.7%-0.2pp | |
| Return on invested capital | 3.9%-3.6pp | 4.1%-4.0pp | 3.6%-5.2pp | 4.8%-4.0pp | 7.5%+0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×-0.7× | 2.3×0.0× | 2.1×-0.2× | 2.1×-0.2× | 2.2×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 1×+0.1× | 0.8×-0.1× | 0.9×-0.1× | 0.8×-0.2× | 0.9×-0.2× | |
| Net debt / EBITDA | 6.1×+2.3× | 5×+1.3× | 5.5×+1.8× | 4.8×+1.2× | 3.8×-0.6× | |
| Per Share | ||||||
| Book value per share | $34.58+7.1% | $33.23+5.9% | $33.17+7.3% | $32.47+8.3% | $32.29+13.9% | |
| Valuation | ||||||
| Market capitalization | $1.47B-9.4% | $1.09B-41.6% | $1.26B-40.5% | $1.46B-34.3% | $1.63B-23.4% | |
| Price / earnings | 26×+11.3× | 19.9×+4.2× | 26.7×+10.8× | 22.7×+5.9× | 14.8×-6.8× | |
| Price / sales | 1.1×-0.2× | 0.8×-0.6× | 0.9×-0.7× | 1.1×-0.6× | 1.2×-0.4× | |
| Price / book | 1.4×-0.2× | 1.1×-0.8× | 1.2×-1.0× | 1.4×-0.9× | 1.6×-0.8× | |
| EV / EBITDA | 15.2×+4.2× | 11.7×0.0× | 13.6×+1.5× | 13.3×+0.8× | 11.1×-3.3× | |
| Dividend yield | 0.8%-0.7pp | 1.7%+0.4pp | 2%+0.8pp | 1.7%+0.6pp | 1.5%+0.4pp |
FAQ
- What are CONMED's profit margins?
- CONMED (CNMD) runs a 55.8% gross margin and a 8.0% operating margin, with a 4.1% net margin.
- Where do CONMED's ratios come from?
- Every ratio is computed from CONMED's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
